WASHINGTON (GenomeWeb News) – A SNP in a dopamine receptor gene appears to interact with childhood exposure to secondhand smoke to modulate lung cancer risk, reported Bríd Ryan, a research fellow at the National Cancer Institute, during the American Association for Cancer Research annual meeting
Caprion Proteome is leading a four-year, C$21 million (US$20.5 million) public-private partnership focused on development and implementation of clinical biomarkers and personalized medicine strategies for oncology.
NEW YORK (GenomeWeb News) – Epic Sciences today said that it has received a Phase II Small Business Innovation Research award from the National Cancer Institute and the National Institutes of Health to develop a lung cancer assay.
Using samples from a study of an experimental chemopreventive drug, iloprost, a team from the University of Colorado Cancer Center has identified a microRNA, miR-34c, that could potentially serve as a surrogate endpoint in lung cancer trials for gauging patients' long-term outcom
Researchers from the British Columbia Cancer Agency this week presented results from a clinical study in which Verisante Technology's Raman spectroscopy-based Core device distinguished between cancerous and benign lung lesions with sensitivity and specificity of more than 90 perc
Enzo Begins Marketing Dx Test for Early Lung Cancer Detection
Enzo Clinical Labs this week launched a diagnostic test to help oncologists detect lung cancer early and gauge which patients are at heightened risk for disease progression.